Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
Provided By GlobeNewswire
Last update: Nov 10, 2025
GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel 2025 Healthcare Conference, being held in New York, NY.
Read more at globenewswire.com
